引用文本：陈泓磊, 乔雨晴, 龚伟. 第7版《日本胃癌治疗指南》内镜治疗部分内容介绍并重要临床问题解读[J/CD]. 消化肿瘤杂志（电子版）, 2025, 17(2):133-140.

作者：陈泓磊¹，乔雨晴¹，龚伟²

单位：1. 中山大学附属第八医院 消化内镜中心，广东 深圳 518033；2. 南方医科大学深圳医院 消化内科，广东 深圳 518000

Authors：Chen Honglei¹, Qiao Yuqing¹, Gong Wei²

Unit：1. Gastrointestinal Endoscopy Center, the Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen 518033, Guangdong, China；2. Department of Gastroenterology, Shenzhen Hospital, Southern Medical University, Shenzhen 518000, Guangdong, China

摘要：

《日本胃癌治疗指南》是日本乃至全球胃癌治疗领域的重要指导性文件，其临床意义重大。2025年3月，日本胃癌学会发布了第7版《日本胃癌治疗指南》，内镜治疗部分较第6版更新了两个临床问题，并将长径≤3 cm、分化型癌为主、pT_1b、水平切缘阴性、垂直切缘阴性、无淋巴管侵犯、无静脉侵犯的情况由内镜根治度（endoscopic curability，eCura）B移入eCuraA，另外定义了新的eCuraB。本文将对该版指南的内镜治疗部分进行解读，并结合国内外实践进行简要总结。

关键词：胃癌；日本；指南解读；内镜治疗

Abstract：

The Japanese gastric cancer treatment guidelines is an important guiding document in the field of gastric cancer treatment not only in Japan but also globally, and it has significant clinical implications. In March 2025, the Japanese Gastric Cancer Association released the 7th edition of the Japanese gastric cancer treatment guidelines. In the endoscopic treatment section, two clinical questions have been updated compared to the 6th edition. And the situation where the long diameter is ≤3 cm, mainly differentiated carcinoma, pT_1b, negative horizontal margin, negative vertical margin, no lymphatic invasion, no venous invasion has been moved from endoscopic curability (eCura) B to eCuraA. In addition, a new eCuraB has been defined. This article will provide an interpretation of the endoscopic treatment section in this edition of the guidelines and briefly summarize it in combination with domestic and international practices.

Key words：Gastric cancer; Japan; Interpretation of guidelines; Endoscopic treatment

注：网络优先发布